Review Article on Nanocarriers in Management of Rheumatoid Arthritis

Abstract

Rheumatoid Arthritis is a Chronic, complicated Inflammatory diseases mostly affect joints. It causes severe pain and persistent inflammation, and it can occasionally cause disability or even early death. Women are 3 to 5 times more likely than males, affecting between 0.3% and 1% of the world's population. Regretfully, there is currently no treatment for RA. Reducing symptoms and making it easier for people to go about their everyday lives is the main objective of therapy. To manage RA, High dosages of nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed by doctors. like celecoxib, etorcoxib, diclofenac, ibuprofen, and indomethacin. Patients may need to take these medications regularly to find relief. On top of that, new strategies are being tested to improve treatment, especially when it comes to delivering medications in a way that’s more comfortable and effective for patients. For example, researchers are exploring the use of topical treatments, which involve applying medication directly to the skin, avoiding some of the side effects that can come from taking pills.